Jazz, Roche’s small cell lung cancer combo snags FDA approval
An FDA approval is setting a new benchmark for future treatment for first-line small cell lung cancer. The…
Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline
Company Logo The market offers key opportunities through the growth of personalized therapies, adoption of monoclonal antibodies, digital…
Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline
Company Logo The market offers key opportunities through the growth of personalized therapies, adoption of monoclonal antibodies, digital…
Jazz-Roche lung cancer combo approved by FDA
The U.S. FDA has approved the priority sNDA for a new first-line maintenance therapy in extensive-stage small-cell lung…